WASHINGTON, Jan. 30, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2019. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2019, net earnings were $792.9 million, or $1.07 per diluted share which represents a... Read more
WASHINGTON, Jan. 23, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has changed the time for its fourth quarter 2019 conference call and webcast. The call will now begin at 7:30 a.m. ET on Thursday, January 30, 2020. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more
WASHINGTON, Jan. 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company’s fourth quarter 2019 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate... Read more
WASHINGTON, Jan. 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2019 on Thursday, January 30, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more
WASHINGTON, Dec. 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today the final results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation (NYSE: NVST) owned by Danaher. The exchange offer expired at... Read more
WASHINGTON, Dec. 16, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today the preliminary results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation (NYSE: NVST) owned by Danaher. The exchange offer expired at 12:00... Read more
WASHINGTON, Dec. 11, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today the final exchange ratio for its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation (NYSE: NVST) owned by Danaher. For each share of Danaher... Read more
WASHINGTON, Nov. 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Evercore ISI HealthCONx Conference on Thursday, December 5, 2019 at 8:45 a.m. ET. The audio will be simultaneously webcast and then archived on www.danaher.com. About DanaherDanaher is a global... Read more
Danaher Will Commence Exchange Offer Related To Divestiture Of Its Remaining Interest In Envista Through A Split-Off WASHINGTON, Nov. 15, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista completed its initial public offering... Read more
Danaher Announces Appointment of Jessica L. Mega, MD, MPH and Pardis C. Sabeti MD, D.Phil to Danaher Board WASHINGTON, Nov. 13, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed Jessica L. Mega, MD, MPH and Pardis C. Sabeti, MD, D.Phil to its Board of Directors. Dr. Mega is currently Chief Medical... Read more